3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
25
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Breast Neoplasms
9
Lymphoma
3
Carcinoma, Hepatocellular
3
Cardiotoxicity
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Recurrence
1
Pseudomyxoma Peritonei
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurotoxicity Syndromes
1
Neoplasm, Residual
1
Neoplasm Metastasis
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Fatigue
1
Fallopian Tube Neoplasms
1
Desmoid Tumors
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
Blood Specimen Collection
4
Drug Therapy
3
mifamurtide
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Patient Reported Outcome Measures
2
Methotrexate
2
glucarpidase
1
X-Rays
1
Weight-Bearing
1
Tomography, X-Ray Computed
1
Therapeutics
1
Surgical Procedures, Operative
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Range of Motion, Articular
1
Radiotherapy
1
Quality of Life
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Molecular Diagnostic Techniques
1
Microbiota
1
Microarray Analysis
1
Metabolome
1
Medical Records
1
Magnetic Resonance Imaging
1
In Situ Hybridization, Fluorescence
1
Immunotherapy
1
HMPL-013
1
Gene Rearrangement
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Osteosarcoma
×
Doxorubicin
×
Clear all
NCT02986503
2016-12-08
EUROBOSS
Italian Sarcoma Group
Completed
100 enrolled